<SEC-DOCUMENT>0001104659-22-107855.txt : 20230209
<SEC-HEADER>0001104659-22-107855.hdr.sgml : 20230209
<ACCEPTANCE-DATETIME>20221011214409
<PRIVATE-TO-PUBLIC>
ACCESSION NUMBER:		0001104659-22-107855
CONFORMED SUBMISSION TYPE:	CORRESP
PUBLIC DOCUMENT COUNT:		3
FILED AS OF DATE:		20221011

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AMCI Acquisition Corp. II
		CENTRAL INDEX KEY:			0001843724
		STANDARD INDUSTRIAL CLASSIFICATION:	INDUSTRIAL ORGANIC CHEMICALS [2860]
		IRS NUMBER:				861763050
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		CORRESP

	BUSINESS ADDRESS:	
		STREET 1:		600 STEAMBOAT ROAD
		CITY:			GREENWICH
		STATE:			CT
		ZIP:			06830
		BUSINESS PHONE:		(203) 625-9200

	MAIL ADDRESS:	
		STREET 1:		600 STEAMBOAT ROAD
		CITY:			GREENWICH
		STATE:			CT
		ZIP:			06830
</SEC-HEADER>
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><IMG SRC="tm225496d7_corresp1img001.jpg" ALT="" STYLE="height: 15px; width: 200px"></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><IMG SRC="tm225496d7_corresp1img002.jpg" ALT=""></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">October 11, 2022</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>VIA EDGAR</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">United States Securities and Exchange Commission</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Division of Corporation Finance</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Office of Life Sciences</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">100 F Street, NE</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Washington, D.C. 20549</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 1in">Attn:</TD><TD STYLE="text-align: justify"><P STYLE="margin-top: 0; margin-bottom: 0">Dillon Hagius</P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0">Laura Crotty</P></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"><B>Re:</B></TD><TD STYLE="text-align: justify"><B>AMCI Acquisition Corp. II</B></TD></TR><TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD STYLE="text-align: justify"><B>Registration Statement on Form&nbsp;S-4</B></TD></TR>
                                                                                                                                          <TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD STYLE="text-align: justify"><B>Filed May&nbsp;10, 2022</B></TD></TR>
                                                                                                                                          <TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD STYLE="text-align: justify"><B>File No.&nbsp;333-264811</B></TD></TR>
                                                                                                                                          </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dear Mr.&nbsp;Hagius / Ms.&nbsp;Crotty:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On behalf of our client,
AMCI Acquisition Corp. II, a Delaware corporation (the &ldquo;<U>Company</U>&rdquo; or &ldquo;<U>AMCI</U>&rdquo;), we are writing to
submit the Company&rsquo;s responses to the comments of the staff of the Division of Corporation Finance (the &ldquo;<U>Staff</U>&rdquo;) of
the United States Securities and Exchange Commission (the &ldquo;<U>Commission</U>&rdquo;) contained in the Staff&rsquo;s letter dated
June&nbsp;9, 2022 (the &ldquo;<U>Comment Letter</U>&rdquo;), with  respect to the above-referenced Registration
Statement on Form&nbsp;S-4, filed on May&nbsp;10, 2022 (the &ldquo;<U>Registration Statement</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company has filed via
EDGAR Amendment No.1 to the Registration Statement (&ldquo;<U>Amendment No.1</U>&rdquo;), which reflects the Company&rsquo;s responses
to the comments received by the Staff and certain updated information. For ease of reference, each comment contained in the Comment Letter
is printed below in bold and is followed by the Company&rsquo;s response. All page&nbsp;references in the responses set forth below refer
to page&nbsp;numbers in Amendment No.1. Capitalized terms used but not defined herein have the meanings set forth in Amendment No.1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Registration Statement on Form&nbsp;S-4 filed
May&nbsp;10, 2022</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>General</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><B>1.</B></TD><TD STYLE="text-align: justify"><B>Please disclose the maximum
                                            redemption level, expressed as a percentage, that would permit completion of the business
                                            combination both on the cover page&nbsp;and where discussed throughout the filing, including,
                                            but not limited to, in relation to the tables on pages&nbsp;12, 14 and 15. We note your disclosure
                                            on page&nbsp;153 to this effect.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Response</U></FONT>:
In response to the Staff&rsquo;s comment, the Company has added disclosure on the cover page and pages 13,  17, 41, 93, 144, 187,
188 and 285 of Amendment No.&nbsp;1 to show the maximum redemption level.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%">United States Securities and Exchange Commission</TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; width: 50%"><IMG SRC="tm225496d7_corresp1img001.jpg" ALT="" STYLE="height: 15px; width: 200px"></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">October 11, 2022</TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Please
                                            identify the PIPE Investors on an individual basis where the term is first used and defined.
                                            Specifically identify those investors that are existing LanzaTech stockholders and describe
                                            other relationships or affiliations with AMCI, LanzaTech, and the Sponsor. Please also identify
                                            the PIPE Investor that has a SAFE Note with LanzaTech. If and when the Proposed Additional
                                            Financing is in place, please provide a description of the material terms of such financing,
                                            including the identit(ies) of the parties involved and their r</B></FONT><B>elationships
                                            or affiliations, if any, with AMCI, LanzaTech, and the Sponsor.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Response</U>:</FONT>&nbsp;In response to the Staff&rsquo;s comment, the Company has revised the disclosure on the cover page. If and when the Proposed
Additional Financing is in place, the Company will provide a description of the material terms of such financing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Questions and Answers about the Business Combination
and the Special Meeting</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>How will I be notified of the outcome of LanzaTech&rsquo;s
stockholder vote to approve the Business Combination?, page&nbsp;13</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><B>3.</B></TD><TD STYLE="text-align: justify"><B>Please revise the above referenced
                                            Q&amp;A to clearly disclose:</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><B>&bull; how AMCI shareholders will
be notified of the outcome of the LanzaTech&rsquo;s stockholder vote regarding the business combination;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><B>&bull; that AMCI may terminate
the agreement if the LanzaTech Requisite Approval is not obtained within ten business days following the effectiveness of this registration
statement; and</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&bull;
</B></FONT><B>the percentage of each class of LanzaTech shares that must vote in favor of the transaction, in addition to those shares
already committed under the LanzaTech Stockholder Support Agreement, in order to satisfy the LanzaTech Requisite Approval requirement.
Note the related risk factor on page&nbsp;81 should also disclose these percentages.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Response</U></FONT>:
In response to the Staff&rsquo;s comment, the Company has revised the disclosure on pages&nbsp;14 and 104 of Amendment No.&nbsp;1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>What happens to the funds deposited in the
Trust Account after consummation of the Business Combination?, page&nbsp;14</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><B>4.</B></TD><TD STYLE="text-align: justify"><B>Please revise this Q&amp;A to
                                            identify the underwriters that are entitled to the deferred underwriting commission of $5,250,000.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Response</U></FONT>:
In response to the Staff&rsquo;s comment, the Company has revised the disclosure on page&nbsp;15 of Amendment No.&nbsp;1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>How will the level of redemptions by AMCI
Stockholders affect my ownership in New LanzaTech following the Closing?, page&nbsp;15</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><B>5.</B></TD><TD STYLE="text-align: justify"><B>Revise your disclosure to show
                                            the potential impact of redemptions on the per share value of the shares owned by non-redeeming
                                            shareholders by including a sensitivity analysis showing a range of redemption scenarios,
                                            including minimum, maximum and multiple interim redemption levels.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Response</U></FONT>:
In response to the Staff&rsquo;s comment, the Company has revised the disclosure on pages&nbsp;16, 17 and 93 of Amendment
No.&nbsp;1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%">United States Securities and Exchange Commission</TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; width: 50%"><IMG SRC="tm225496d7_corresp1img001.jpg" ALT="" STYLE="height: 15px; width: 200px"></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">October 11, 2022</TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>What interests do the Sponsor and AMCI&rsquo;s current
officers and directors have in the Business Combination?, page&nbsp;20</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><B>6.</B></TD><TD STYLE="text-align: justify"><B>Please quantify the out-of-pocket
                                            expenses and loans that are at risk if the business combination does not occur and provide
                                            more specificity about how the board considered the potential conflicts listed in this section
                                            when negotiating and recommending the business combination. Similarly revise the conflicts
                                            disclosure on pages&nbsp;35, 68, and 109.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Response</U></FONT>:
In response to the Staff&rsquo;s comment, the Company has added disclosures on pages&nbsp;24, 39, 80 and 142 of Amendment
No.&nbsp;1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><B>7.</B></TD><TD STYLE="text-align: justify"><B>We note your disclosure on page&nbsp;21
                                            that the AMCI Insiders have waived any right to redemption with respect to the founder shares.
                                            Please describe any consideration provided in exchange for this agreement.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Response</U></FONT>:
In response to the Staff&rsquo;s comment, the Company has revised the disclosure on pages&nbsp;23, 38, 80 and 142 of Amendment
No.&nbsp;1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><B>8.</B></TD><TD STYLE="text-align: justify"><B>Please disclose which of your
                                            independent directors are members of the Sponsor. Similarly revise the conflicts disclosure
                                            on pages&nbsp;35, 68, and 109.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Response</U></FONT>:
In response to the Staff&rsquo;s comment, the Company has revised disclosures on pages&nbsp;24, 39, 80 and 142 of Amendment
No.&nbsp;1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Summary of the Proxy Statement/Prospectus
Information About the Parties to the Business Combination, page&nbsp;27</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><B>9.</B></TD><TD STYLE="text-align: justify"><B>Please provide additional information
                                            about LanzaTech in the Summary section, including a discussion of the stage of development
                                            of its Platform Technology and products, its history of net losses, accumulated deficit,
                                            and its expectations around revenue generation. As currently drafted, shareholders are provided
                                            with little information regarding the business history or prospects of the target business,
                                            which is material to a decision of how to vote in relation to the proposed business combination.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Response</U></FONT>:
In response to the Staff&rsquo;s comment, the Company has revised the disclosure on pages 29 and 30 of Amendment No.&nbsp;1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Interests of AMCI&rsquo;s Directors and Officers
in the Business Combination, page&nbsp;35</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><B>10.</B></TD><TD STYLE="text-align: justify"><B>Please confirm that the conflicts
                                            of interest discussion highlights all material interests in the transaction held by the sponsor
                                            and the company&rsquo;s officers and directors. This could include fiduciary or contractual
                                            obligations to other entities as well as any interest in, or affiliation with, the target
                                            company. In addition, please revise your disclosure to clarify how the board considered those
                                            conflicts in negotiating and recommending the business combination.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Response</U></FONT>:
In response to the Staff&rsquo;s comment, the Company has revised the disclosure on pages&nbsp;22, 23, 37, 38, 79 and 141 of
Amendment No.&nbsp;1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%">United States Securities and Exchange Commission</TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; width: 50%"><IMG SRC="tm225496d7_corresp1img001.jpg" ALT="" STYLE="height: 15px; width: 200px"></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">October 11, 2022</TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Risk Factors</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Risks Related to LanzaTech&rsquo;s Business
and Industry</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Our financial projections may differ materially
from actual results., page&nbsp;50</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><B>11.</B></TD><TD STYLE="text-align: justify"><B>Please revise your statement
                                            that &ldquo;[n]either we nor AMCI have any duty to update the financial projections included
                                            in this proxy statement/prospectus&rdquo; to confirm that you will update or revise such disclosure
                                            to the extent required by law.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Response</U></FONT>:
In response to the Staff&rsquo;s comment, the Company has revised the disclosure on page&nbsp;57 of Amendment No.&nbsp;1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>We expect to rely on a limited number of industry
partners for a significant portion of our near-term revenue., page&nbsp;56</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><B>12.</B></TD><TD STYLE="text-align: justify"><B>Please identify the industry
                                            partners from which you expect to generate &ldquo;most of your revenues in the near future.&rdquo;
                                            Confirm that this assumption was included in LanzaTech&rsquo;s internally prepared forecasts, which
                                            you discuss on page&nbsp;105, and specify how you define the term &ldquo;near future&rdquo;
                                            in the context of these projections, the latter of which we note include each of the years
                                            in the five-year period ending December&nbsp;31, 2026.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Response</U></FONT>:
The Company respectfully acknowledges the Staff&rsquo;s comment and advises the Staff that the industry partners referenced in the
Registration Statement from which LanzaTech expects to generate most of its revenues in the near future include Suncor <FONT STYLE="color: #231f20">Energy
Inc.</FONT>,&nbsp;IndianOil Corporation Limited, Mitsui&nbsp;<FONT STYLE="color: #231f20">&amp; Co.,&nbsp;Ltd.</FONT>, Sekisui <FONT STYLE="color: #231f20">Chemical
Co.,&nbsp;Ltd. ArcelorMittal XCarb S.&agrave;.r.l., Woodside Energy, MRPL,</FONT> and Beijing Shougang LanzaTech Technology Co.,&nbsp;Ltd. The Company respectfully confirms that LanzaTech
included this assumption in its internally prepared forecasts. In the context of such forecasts and projections, the Company
respectfully advises the Staff that the term &ldquo;near future&rdquo; relates to the projections and forecasts through
December&nbsp;31, 2023.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">In response to the Staff&rsquo;s comment,
the Company has revised the disclosure on page 63 of Amendment No. 1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Political and economic uncertainty, including
changes in policies of the Chinese government or in relations between China..., page&nbsp;63</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>13.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>We
                                            note the above entitled risk factor discussing your operations in China, your joint venture
                                            and your joint venture partners in China, and certain of your strategic investors located
                                            in China, including Sinopec Capital Co,&nbsp;Ltd. Please revise your filing, as applicable,
                                            to provide more specific and prominent disclosures about the legal and operational risks
                                            associated with China-based companies or explain why such comments</B></FONT><B> are not
                                            applicable to the company. Please see the Division of Corporation Finance&rsquo;s Sample Letter
                                            to China-Based Companies issued by the Staff in December&nbsp;2021 for the issues to be considered
                                            and addressed.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Response</U></FONT>:
The Company respectfully acknowledges the Staff&rsquo;s comment and advises the Staff that LanzaTech is not a China-based company.
LanzaTech is headquartered in the United States and its executive team sits in Chicago,&nbsp;Illinois with a stake in a Chinese
joint venture and some employees located in China. Though the first three plants operated by LanzaTech&rsquo;s partners to commence
operations using LanzaTech&rsquo;s technology are located in China, LanzaTech has worked with its partners to enable numerous
projects under construction using LanzaTech&rsquo;s process technology in other locations including the United States, Belgium,
Canada, Japan and India. Additionally, LanzaTech has projects in various stages of development in the United Kingdom, India,
Portugal, the Netherlands,&nbsp;Italy, Sweden and Australia. LanzaTech was founded and headquartered in New Zealand until 2014 when
LanzaTech relocated to its current headquarters in Chicago. Accordingly, the Company respectfully advises the Staff that the Company
does not believe that the legal and operational risks associated with China-based companies are materially applicable to
LanzaTech&rsquo;s business or that such risks are significantly different from risks facing many other U.S.-based companies with
partnerships or other operations in China. Because LanzaTech does business in China and has a joint venture and other partners
located in China, the Company has revised the disclosure on pages 72-73 of Amendment No.&nbsp;1 in response to the
Staff&rsquo;s comment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%">United States Securities and Exchange Commission</TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; width: 50%"><IMG SRC="tm225496d7_corresp1img001.jpg" ALT="" STYLE="height: 15px; width: 200px"></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">October 11, 2022</TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Some of our intellectual property may be subject
to federal regulation such as march-in rights..., page&nbsp;66</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><B>14.</B></TD><TD STYLE="text-align: justify"><B>Please revise to identify which
                                            of your intellectual property rights is or may be subject to march-in rights connected to
                                            grants from U.S. government agencies. Please also provide disclosure to this effect in the
                                            Business section, where appropriate.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Response</U></FONT>:
In response to the Staff&rsquo;s comment, the Company has revised the disclosure on pages&nbsp;77 and 231 of Amendment No.&nbsp;1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Risks Related to AMCI and the Business Combination,
page&nbsp;68</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><B>15.</B></TD><TD STYLE="text-align: justify"><B>Please highlight the material
                                            risks to public warrant holders, if any, arising from the differences between private warrants,
                                            LanzaTech Warrants, and public warrants.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Response</U></FONT>:
In response to the Staff&rsquo;s comment, the Company has revised the disclosure on pages 87-88 of Amendment No.&nbsp;1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><B>16.</B></TD><TD STYLE="text-align: justify"><B>Your current charter limits
                                            the application of the doctrine of corporate opportunity under certain circumstances. Please
                                            address this potential conflict of interest in a separate risk factor and indicate whether
                                            it impacted your search for an acquisition target.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Response</U></FONT>:
In response to the Staff&rsquo;s comment, the Company has revised the disclosure on page 86 of Amendment No.&nbsp;1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Our warrant agreement designates the courts
of the State of New York or the United States District Court for the Southern District..., page&nbsp;71</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><B>17.</B></TD><TD STYLE="text-align: justify"><B>Please revise this risk factor
                                            to disclose that there is also a risk that your exclusive forum provision may result in increased
                                            costs for investors to bring a claim. Please similarly revise the risk factor on page&nbsp;82
                                            concerning the exclusive forum provision in LanzaTech&rsquo;s certificate of incorporation.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Response</U></FONT>:
In response to the Staff&rsquo;s comment, the Company has revised the disclosure on page&nbsp;105 of Amendment No.&nbsp;1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%">United States Securities and Exchange Commission</TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; width: 50%"><IMG SRC="tm225496d7_corresp1img001.jpg" ALT="" STYLE="height: 15px; width: 200px"></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">October 11, 2022</TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Our stockholders will experience immediate
dilution as a consequence of the issuance of New LanzaTech Common Stock as consideration..., page&nbsp;75</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><B>18.</B></TD><TD STYLE="text-align: justify"><B>Please revise to disclose all
                                            possible sources and extent of dilution that shareholders who elect not to redeem their shares
                                            may experience in connection with the business combination. Provide disclosure of the impact
                                            of each significant source of dilution, including the amount of equity held by founders,
                                            convertible securities, including warrants retained by redeeming shareholders, at each of
                                            the redemption levels detailed in your sensitivity analysis, including any needed assumptions.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Response</U></FONT>:
In response to the Staff&rsquo;s comment, the Company has revised the disclosure on pages&nbsp;93 and 94 of Amendment No.&nbsp;1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><B>19.</B></TD><TD STYLE="text-align: justify"><B>Quantify the value of warrants,
                                            based on recent trading prices, that may be retained by redeeming stockholders assuming maximum
                                            redemptions and identify any material resulting risks.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Response</U></FONT>:
In response to the Staff&rsquo;s comment, the Company has revised the disclosure on pages&nbsp;93 and 94 of Amendment No.&nbsp;1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Background of the Business Combination, page&nbsp;92</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><B>20.</B></TD><TD STYLE="text-align: justify"><B>Please revise to specifically
                                            identify the following persons or entities:</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><B>&bull; each person or entity that
composes the AMCI Group (refer to page&nbsp;92);</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><B>&bull; the &ldquo;consultant specializing
in blast furnaces and steel off-gases&rdquo; with whom you had a discussion on October&nbsp;14, 2021 (refer to page&nbsp;95)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><B>&bull; each of the &ldquo;various market
experts&rdquo; with whom you held calls to further understand global end-market dynamics for LanzaTech&rsquo;s products (refer to page&nbsp;97).</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Response</U></FONT>:
In response to the Staff&rsquo;s comment, the Company has revised the disclosure on page&nbsp;2 of Amendment No.&nbsp;1 to identify
each person or entity that composes the group of AMCI Insiders. The Company respectfully informs the Staff that none of the consultant
or the other market experts disclosed in the Registration Statement were formally engaged by the Company or LanzaTech to provide advice,
none are employed by or are affiliates of either the Company or LanzaTech and none have a direct interest in the Business Combination.
The Company does not believe that the identity of these individuals and entities is material to an investment decision. In light of the
foregoing, the Company respectfully submits that the Company is not required to provide their identities under Regulation MA or any of
the other rules&nbsp;of the Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><B>21.</B></TD><TD STYLE="text-align: justify"><B>Please disclose when AMCI engaged
                                            both Evercore and Goldman Sachs to act as its capital markets advisors. As it concerns Goldman
                                            Sachs, please expand your disclosure to more specifically explain the scope of this agreement,
                                            including the role Goldman Sachs played with respect to valuation, analysis and due diligence
                                            and the agreement&rsquo;s proposed fee structure. Please also disclose whether Goldman Sachs provided
                                            AMCI with a report, opinion or appraisal for the proposed business combination at any time
                                            prior to its resignation on May&nbsp;6, 2022.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Response</U></FONT>:
In response to the Staff&rsquo;s comment, the Company has revised the disclosure on pages&nbsp;122, 124 and 126-129 of Amendment No.&nbsp;1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%">United States Securities and Exchange Commission</TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; width: 50%"><IMG SRC="tm225496d7_corresp1img001.jpg" ALT="" STYLE="height: 15px; width: 200px"></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">October 11, 2022</TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><B>22.</B></TD><TD STYLE="text-align: justify"><B>We note that AMCI evaluated
                                            &ldquo;numerous&rdquo; target business candidates after its IPO and entered into 20 confidentiality
                                            agreements with potential target companies. Please explain how you narrowed to these 20 targets
                                            and briefly explain why and when each was eliminated as a potential target. Please also include
                                            additional disclosure concerning the timeline of your negotiations with the other target
                                            company to which AMCI submitted a non-binding letter of intent. Your disclosure in this section
                                            should provide shareholders with an understanding of why other target companies were not
                                            ultimately chosen as business combination partners.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Response</U></FONT>:
In response to the Staff&rsquo;s comment, the Company has revised the disclosure on pages&nbsp;116 and 119 of Amendment No.&nbsp;1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><B>23.</B></TD><TD STYLE="text-align: justify"><B>In addition to the $4.6 million
                                            payable to Evercore as deferred underwriting compensation, please disclose the total fees
                                            that Barclays Capital Inc. and Evercore Group, L.L.C. will receive upon completion of the
                                            business combination and any amount that is contingent upon completion of the transaction
                                            for serving as financial advisors. Please also disclose, on a firm-by-firm basis, the amount
                                            of fees attributable to capital markets advisory services and the amount attributable to
                                            placement agent services.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Response</U></FONT>:
In response to the Staff&rsquo;s comment, the Company has revised the disclosure on page&nbsp;122 of Amendment No.&nbsp;1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><B>24.</B></TD><TD STYLE="text-align: justify"><B>When discussing Goldman Sachs&rsquo;
                                            May&nbsp;6, 2022 resignation, please describe the services that remained outstanding from
                                            Goldman Sachs that would have been required in order to earn the fees that you indicate have
                                            been forfeited. For example, if Goldman Sachs would have played a role in the closing of
                                            the business combination, please revise to identify the party who will be filling this role.
                                            Additionally, please discuss the potential impact on the transaction related to this resignation.
                                            This discussion should address the fact that, in its role as capital markets advisor, Goldman
                                            Sachs assisted in the creation of the Selected Public Company Analysis (as disclosed on page&nbsp;103)
                                            and the identification of potential PIPE Investors (as disclosed on page&nbsp;98).</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Response</U></FONT>:
In response to the Staff&rsquo;s comment, the Company has revised the disclosure on pages&nbsp;126-129 of Amendment No.&nbsp;1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Financial Analysis, page&nbsp;103</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><B>25.</B></TD><TD STYLE="text-align: justify"><B>We note that the AMCI Board
                                            did not seek a third-party valuation and did not receive any valuation report or opinion
                                            from a third party in connection with the business combination. Please revise to explain
                                            why the AMCI Board determined that it was not necessary to obtain a fairness opinion for
                                            the business combination. Additionally, revise to disclose all material factors that the
                                            AMCI Board relied upon in agreeing to the current valuation, clarifying the &ldquo;other things&rdquo;
                                            the Board considered.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Response</U></FONT>:
In response to the Staff&rsquo;s comment, the Company has revised the disclosure on pages&nbsp;44, 96, 97 and 133 of Amendment
No.&nbsp;1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%">United States Securities and Exchange Commission</TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; width: 50%"><IMG SRC="tm225496d7_corresp1img001.jpg" ALT="" STYLE="height: 15px; width: 200px"></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">October 11, 2022</TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Certain LanzaTech Projected Financial Information,
page&nbsp;105</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><B>26.</B></TD><TD STYLE="text-align: justify"><B>We note the term of the projections
                                            through 2026. Please explain the basis for providing projections beyond year three and clarify
                                            if the forecasts reflect more than simple assumptions about growth rates. It should be clear
                                            how projected growth rates are sustainable over the selected period of time and why it is
                                            reasonable to assume such growth rates.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Response</U></FONT>:&nbsp;In
response to the Staff&rsquo;s comment, the Company has revised the disclosure on page&nbsp;136-140 of Amendment No.&nbsp;1. The
Company respectfully acknowledges the Staff&rsquo;s comment and advises the Staff that following a review of LanzaTech&rsquo;s
forecasting methodologies, its year to date performance, and a review of opportunities in its pipeline, LanzaTech management revised
its financial projection forecast to account for changes in the overall global macroeconomic climate, including geopolitical
tensions, supply chain disruptions, increasing inflation, and higher interest rates that have impacted LanzaTech&rsquo;s partners&rsquo; decision
making processes and broader project development cycles over the forecast period. The revised forecast was approved by
LanzaTech&rsquo;s Board of Directors on September 7, 2022 and shared with the Company on September 8, 2022. The revised forecast reflects
LanzaTech&rsquo;s latest views on its project pipeline, the timing and probability of specific projects advancing through the
pipeline, adjustments in the revenue recognition structure of its CarbonSmart business, modifications to the accounting treatment of
LanzaJet as a LanzaTech equity method investee, and modifications to its co-development model, which focuses on the utilization of
third-party capital from recently established partnerships to invest in  projects where LanzaTech takes a more active
project development role. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">Additionally, the Company advises the
Staff that the original and revised forecasts reflect more than simple assumptions about growth rates. The Company respectfully advises
the Staff that LanzaTech&rsquo;s business model centers around licensing its technology to partners who own and operate the facilities,
the full project development  cycle for which can range from 24-36 months depending on the geography, feedstock, and integration
of a particular project. The Company notes that LanzaTech utilizes several forecasting methodologies to derive a weighted probability
that each of its projects will advance through the project development cycle. LanzaTech&rsquo;s management believes that this sales cycle
and pipeline commercialization forecasting methodology allows for reasonable projections through 2026, which is when LanzaTech&rsquo;s
management believes that its current pipeline of projects will become fully operational. LanzaTech management expects to continue to add
to its pipeline of licensing opportunities, consistent with the large addressable market for its approach, and will continue to apply
its probability-weighted conversion assumptions to these additional opportunities. For joint development and contract research, including
government grants, LanzaTech has assumed modest growth rates associated with these revenue streams and has assumed that these revenue
streams represent a declining percentage of LanzaTech&rsquo;s overall revenues over the projection term.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><B>27.</B></TD><TD STYLE="text-align: justify"><B>We have the following comments
                                            regarding the assumptions presented in your projected financial information:</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><B>&bull; Revise to disclose in more
detail the material assumptions underlying the projected financial information rather than merely list the factors that could affect
the figures presented;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><B>&bull; Quantify the underlying operational
and market assumptions discussed in the third to last paragraph on page&nbsp;108 to the extent possible;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><B>&bull; Explain how the projected information
currently disclosed is representative of your current and expected future joint development agreements, U.S. government R&amp;D contracts,
and collaboration agreements;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><B>&bull; Explain the relationship between
your current and expected installed capacity and how you expect it to result in the increase in recurring revenues over the periods presented.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Response</U></FONT>:
In response to the Staff&rsquo;s comment, the Company has revised the disclosure on pages 136-140 of Amendment No.&nbsp;1
based on the first and second bullets above. In response to the third bullet above, the Company respectfully acknowledges the
Staff&rsquo;s comment and advises the Staff that all signed and contracted engagements are included within the revenue forecasts for
joint development agreements, U.S. government research and development contracts, and collaboration agreements. The forecasts assumes growth rates for these types of projects based on historical conversion and expected growth in the availability of such funding. The per
project economic assumptions associated with these projects are consistent with LanzaTech&rsquo;s historic and ongoing joint
development and contract research agreements. In response to the fourth bullet above, the Company respectfully acknowledges the
Staff&rsquo;s comment and advises the Staff that as additional plants come online over the forecast period, LanzaTech&rsquo;s
management expects that recurring revenue will represent a growing proportion of its overall revenue mix. LanzaTech&rsquo;s
recurring revenue is largely comprised of licensing royalties, typically calculated as a percentage of sales of the relevant product
produced by the licensed facility, in addition to recurring sales of microbes and media and software and monitoring services, and
will therefore increase as additional capacity is brought online over the forecast period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%">United States Securities and Exchange Commission</TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; width: 50%"><IMG SRC="tm225496d7_corresp1img001.jpg" ALT="" STYLE="height: 15px; width: 200px"></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">October 11, 2022</TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><B>28.</B></TD><TD STYLE="text-align: justify"><B>We note your statements on
                                            this page&nbsp;that investors &ldquo;are cautioned not to place undue reliance on the prospective
                                            financial information&rdquo; of LanzaTech&rsquo;s projected financial information and are &ldquo;cautioned
                                            not to rely on the projections in making a decision regarding the Business Combination[.]&rdquo;
                                            Please revise these statements to remove any implication that investors are not entitled
                                            to rely on disclosure in your registration statement.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Response</U></FONT>:
In response to the Staff&rsquo;s comment, the Company has revised the disclosure on page&nbsp;137 of Amendment No.&nbsp;1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><B>29.</B></TD><TD STYLE="text-align: justify"><B>You disclose that LanzaTech
                                            provided AMCI with its internally prepared forecasts for each of the years in the five-year
                                            period ending December&nbsp;31, 2026. Please disclose when these projections were prepared.
                                            In this regard, we note your disclosure on page&nbsp;94 that on September&nbsp;13, 2021,
                                            AMCI had a call with LanzaTech to walk through its financial model and associated projections
                                            in detail. Please explain whether or not the projections still reflect management&rsquo;s
                                            views on future performance and describe what consideration the board gave to obtaining updated
                                            projections.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Response</U></FONT>:
In response to the Staff&rsquo;s comment, the Company has revised the disclosure on pages 136-140 of Amendment No.&nbsp;1. LanzaTech
first prepared projections that were used in connection with negotiations leading up to the Letter of Intent signed with the Company.
The Company and LanzaTech discussed these projections initially on September&nbsp;13, 2021 as part of the Company&rsquo;s ongoing due
diligence effort. Following the execution of the Letter of Intent, LanzaTech prepared an updated financial forecast on January&nbsp;6,
2022, to reflect the change in financial period, to incorporate an updated project pipeline, and to reflect updated accounting treatment
relating to the transition from IFRS to U.S. GAAP in connection with LanzaTech&rsquo;s migration from New Zealand to Delaware. This updated
financial forecast was the basis of the projections presented in the Registration Statement and served as the basis of the Company Board&rsquo;s
decisions to proceed with entering into the Merger Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">From time to time, LanzaTech
assesses its projections to ensure they still reflect managements&rsquo; good faith estimates of future performance. Following a
review of LanzaTech&rsquo;s forecasting methodologies, its year to date performance, and a review of opportunities in its pipeline,
LanzaTech management revised its financial projection forecast to account for changes in the overall global macroeconomic climate,
including geopolitical tensions, supply chain disruptions, increasing inflation, and higher interest rates that have impacted
LanzaTech&rsquo;s  partners&rsquo; decision making processes and broader project development cycles over the forecast period. The
revised forecast was approved by LanzaTech&rsquo;s Board of Directors on September 7, 2022 and shared with AMCI on September 8,
2022. The revised forecast reflects LanzaTech&rsquo;s latest views on its project pipeline, the timing and probability of specific
projects advancing through the pipeline, adjustments in the revenue recognition structure of its CarbonSmart business, modifications
to the accounting treatment of LanzaJet as a LanzaTech equity method investee, and modifications to its co-development model, which
focuses on the utilization of third-party capital from recently established partnerships to invest in projects where LanzaTech takes
a more active project development role. Into select project opportunities, LanzaTech will continue to directly deploy equity capital
in amounts that represent a minority stake in the overall project equity. In light of these revised projections, the Company has
revised the disclosure on pages 136-140 of Amendment No. 1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%">United States Securities and Exchange Commission</TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; width: 50%"><IMG SRC="tm225496d7_corresp1img001.jpg" ALT="" STYLE="height: 15px; width: 200px"></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">October 11, 2022</TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><B>30.</B></TD><TD STYLE="text-align: justify"><B>We note your disclosure on
                                            page&nbsp;106 that AMCI relied on numerous estimates and certain assumptions, including certain
                                            of those listed on this page. Please disclose all the material estimates and assumptions
                                            relied upon by the LanzaTech management team. In this regard, please clarify what &ldquo;other
                                            assumptions&rdquo; were &ldquo;impacted by the reality that research, product development,
                                            project timelines, operational execution, and downstream product demand are difficult to
                                            predict and will be impacted by numerous circumstances that are out of LanzaTech&rsquo;s
                                            control.&rdquo; Similarly, as it concerns your disclosure on page&nbsp;108, revise this section
                                            to disclose all material projections rather than limiting the information to the &ldquo;key
                                            elements&rdquo; thereof.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Response</U></FONT>:
In response to the Staff&rsquo;s comment, the Company has revised the disclosure on pages&nbsp;136-140 of Amendment No.&nbsp;1.
No additional material estimates, assumptions or projections were relied upon by LanzaTech&rsquo;s management team.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Certain Engagements in Connection with the
Business Combination and Related Transactions, page&nbsp;112</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><B>31.</B></TD><TD STYLE="text-align: justify"><B>Please revise your statement
                                            that Evercore was engaged by AMCI to act as &ldquo;sole financial advisor and capital markets
                                            advisor&rdquo; to AMCI in connection with the business combination, as this does not appear
                                            consistent with the fact that AMCI also retained Goldman Sachs to act as a capital markets
                                            advisor at one point in time.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Response</U></FONT>:
In response to the Staff&rsquo;s comment, the Company has revised the disclosure on page&nbsp;144 of Amendment No.&nbsp;1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Information About LanzaTech</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Overview, page&nbsp;179</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><B>32.</B></TD><TD STYLE="text-align: justify"><B>Please revise the Overview
                                            section on page&nbsp;179 to clarify whether the company&rsquo;s current commercial operations are
                                            all located in China. In this regard, we that you do not discuss the carbon capture and transformation
                                            facility at ArcelorMittal&rsquo;s steel mill in Ghent, Belgium in the Overview. Please clarify
                                            what role such facility plays in the company&rsquo;s operations. Please also disclose where the
                                            &ldquo;numerous projects in construction, under development, and in the pipeline&rdquo; are
                                            located and provide details about each, to the extent material.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Response</U></FONT>:
In response to the Staff&rsquo;s comment, the Company has revised the disclosure on page&nbsp;216 of Amendment No.&nbsp;1. The
facility being built by ArcelorMittal at its steel mill in Ghent, Belgium is currently under construction and is not material to the
Company&rsquo;s current commercial operations. Likewise, the other projects in construction, under development and in the pipeline
are not material to LanzaTech&rsquo;s current commercial operations. The other five projects currently in construction are the
following: the LanzaJet Freedom Pines facility in Georgia, United States; the Shougang ferroalloy project in China; the Sekisui
gasified Municipal Solid Waste facility in Japan; the Suncor gasified biomass project in  Canada; and the IndianOil
Corporation refinery off gas facility in India. The projects under engineering development are the following: a gasified biomass
facility in Portugal; a sustainable aviation fuel project in the Netherlands; the NextChem gasified municipal solid waste facility
in Italy; a sustainable aviation fuel project in the United Kingdom; the Woodside biogas facility in Australia; the SED gasified
biomass facility in India; the Vattenfall CO<SUB>2</SUB> + green H<SUB>2</SUB> project in Sweden; and the MRPL gasified biomass
facility in India.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%">United States Securities and Exchange Commission</TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; width: 50%"><IMG SRC="tm225496d7_corresp1img001.jpg" ALT="" STYLE="height: 15px; width: 200px"></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">October 11, 2022</TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><B>33.</B></TD><TD STYLE="text-align: justify"><B>We note your comparison of
                                            your technology platform to the brewing process. Please revise this statement to note the
                                            novel nature of your technology platform, which you disclose on page&nbsp;55, and to specify
                                            the nature of your end products, which you disclose on pages&nbsp;188 to 192.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Response</U></FONT>:
In response to the Staff&rsquo;s comment, the Company has revised the disclosure on page&nbsp;216 of Amendment No.&nbsp;1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Intellectual Property, page&nbsp;192</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><B>34.</B></TD><TD STYLE="text-align: justify"><B>We note your disclosure that
                                            your intellectual property portfolio is comprised of 1,115 patents and over 470 pending patent
                                            applications across 119 patent families across your overall technology platform. For each
                                            material patent or patent family, please revise your disclosure to include the specific products
                                            or technologies to which the patents relate, the type of patent protection obtained (composition
                                            of matter, use or process), the jurisdiction of the patents and the expiration year. If any
                                            of these patents are in-licensed, please specify. In this regard it may be useful to provide
                                            tabular disclosure in addition to the narrative.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Response</U></FONT>:
In response to the Staff&rsquo;s comment, the Company has revised the disclosure on page 230 of Amendment No.&nbsp;1. LanzaTech
is a technology company which protects its intellectual property across an entire platform through a combination of trade secrets, confidential
information, patents, trademarks, copyrights, nondisclosure agreements, material transfer agreements, employee agreements, and strong
intellectual property and confidentiality clauses in collaboration and other agreements. LanzaTech does not consider any individual patent,
patent family or trademark to be material to its overall business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Key Collaboration Agreements, page&nbsp;193</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><B>35.</B></TD><TD STYLE="text-align: justify"><B>Please revise the description
                                            of the following agreements to disclose: (1)&nbsp;the amount paid or received to date from
                                            upfront payments, milestone payments, and/or royalties; (2)&nbsp;the aggregate potential
                                            milestone payments, and; (3)&nbsp;royalty rates (to a range that does not exceed ten percentage
                                            points):</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><B>&bull; License
Agreement with Battelle Memorial Institute;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><B>&bull; License
Agreement with LanzaJet;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><B>&bull; Shougang
Joint Venture License Agreement;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><B>&bull; Agreements
with Sekisui Chemical Co., Ltd;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><B>&bull; Letter
Agreement with IndianOil;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><B>&bull; Suncor
License Agreement.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Response</U></FONT>:
In response to the Staff&rsquo;s comment, the Company has revised the disclosure on pages&nbsp;231-240 of Amendment No.&nbsp;1. The
Company respectfully acknowledges the Staff&rsquo;s comment and advises the Staff that the descriptions of each of the abovementioned
agreements have been updated to include these terms for each agreement. However, several of these agreements do not include these provisions:
LanzaTech&rsquo;s license agreement with LanzaJet does not include its own consideration terms, instead incorporating the terms from LanzaTech&rsquo;s
license agreement with Battelle Memorial Institute; the agreements with Sekisui Chemical Co., Ltd do not include payment terms; and none
of the abovementioned agreements provide for milestone payments.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%">United States Securities and Exchange Commission</TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; width: 50%"><IMG SRC="tm225496d7_corresp1img001.jpg" ALT="" STYLE="height: 15px; width: 200px"></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">October 11, 2022</TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Shougang LanzaTech Joint Venture, page&nbsp;195</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><B>36.</B></TD><TD STYLE="text-align: justify"><B>Please revise your disclosure
                                            to provide a diagram of Beijing Shougang LanzaTech Technology Co.,&nbsp;Ltd.&rsquo;s corporate
                                            structure and identify the persons or entities that own the equity in each depicted entity.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Response</U></FONT>:
The Company respectfully acknowledges the Staff&rsquo;s comment and has supplementally provided to the Staff a diagram of the corporate structure
of Beijing Shougang LanzaTech Technology Co.,&nbsp;Ltd. identifying the persons or entities that own equity in each depicted entity and
including the percentage of the equity of each entity held by each of these parties. The Company respectfully advises the Staff that
because LanzaTech only holds approximately 9.3% of the equity of Beijing Shougang LanzaTech Technology Co.,&nbsp;Ltd. through its subsidiary,
LanzaTech Hong Kong Limited, and such ownership percentage is disclosed in the Registration Statement, the corporate structure and identities
of the other shareholders in Beijing Shougang LanzaTech Technology Co.,&nbsp;Ltd., none of which are affiliates of LanzaTech, are not
material to LanzaTech&rsquo;s business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Management&rsquo;s Discussion and Analysis of Financial
Condition and Results of Operations of</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>LanzaTech, page&nbsp;202</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><B>37.</B></TD><TD STYLE="text-align: justify"><B>We note your disclosure on
                                            page&nbsp;207 that you hold interests in certain VIEs. Please revise your disclosure to identify
                                            whether you have any contractual arrangements with VIEs based in China and whether these
                                            VIEs are connected to the letter agreement with Sinopec Capital Co,&nbsp;Ltd. and/or the
                                            Shougang Joint Venture.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Response</U></FONT>:
In response to the Staff&rsquo;s comment, the Company has revised the disclosure on page 249 of Amendment No.&nbsp;1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Management&rsquo;s Discussion and Analysis of Financial
Condition and Results of Operations of LanzaTech Results of Operations, Comparisons of the Years Ended December&nbsp;31, 2021 and 2020,
Revenues, page&nbsp;208</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><B>38.</B></TD><TD STYLE="text-align: justify"><B>We reference the disclosure
                                            that the net impact of joint development agreements increased revenues by $4.8 million due
                                            to new collaborative arrangements and continued collaborations with existing customers. Please
                                            revise to quantify the increase in revenues related to new collaborative arrangements versus
                                            those with existing customers.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Response</U></FONT>:
In response to the Staff&rsquo;s comment, the Company has revised the disclosure on page 252 of Amendment No.&nbsp;1. The Company respectfully
acknowledges the Staff&rsquo;s comment and advises the Staff that during the year ended December 31, 2021, the net impact of joint development
agreements increased LanzaTech&rsquo;s revenues by $4.8 million due to $1.5 million in collaborative arrangements from new customers and
$3.3 million in continued collaborations with existing customers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Beneficial Ownership of Securities , page&nbsp;239</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><B>39.</B></TD><TD STYLE="text-align: justify"><B>Please identify in footnotes
                                            to the table all natural persons who have voting and/or investment power over the shares
                                            held by Guardians of New Zealand Superannuation, Sinopec Capital,&nbsp;Co. Ltd, and Novo
                                            Holdings A/S.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Response</U></FONT>:
In response to the Staff&rsquo;s comment, the Company has revised the disclosure on page 288 of Amendment No.&nbsp;1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%">United States Securities and Exchange Commission</TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; width: 50%"><IMG SRC="tm225496d7_corresp1img001.jpg" ALT="" STYLE="height: 15px; width: 200px"></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">October 11, 2022</TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Certain Relationships and Related Party Transactions,
page&nbsp;256</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>40.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Please
                                            identity the Anchor Investors and expand your disclosure to specifically describe any related
                                            party affiliation. To the extent any of your sponsors, directors, officers or their affiliates
                                            helped facilitate agreements with the Anchor Investors, please disclose the specific role
                                            they played in doing so in the &ldquo;Background of the Business Combination&rdquo; </B></FONT><B>section
                                            on page&nbsp;92.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Response</U></FONT>:
In response to the Staff&rsquo;s comment, the Company has revised the disclosure on pages&nbsp;287 and 306 of Amendment No.&nbsp;1
to disclose that none of the Anchor Investors are related persons as such term is defined in Item 404(a)&nbsp;of Regulation SK and also
to identify those Anchor Investors who are holders of 5% or more of the Company&rsquo;s securities. The Company respectfully submits that
the omission of the identities of other Anchor Investors is neither material nor required under Commission rules and regulations. In this
regard, the Company advises the Staff that, to its knowledge, none of the Anchor Investors will own more than 5% of New LanzaTech upon
the Closing. Further, the Company respectfully advises the Staff that Evercore, in its capacity as underwriter of the Company&rsquo;s
IPO, helped to facilitate the agreements with such investors and the Company has revised the disclosure on page&nbsp;306 of Amendment
No.&nbsp;1 accordingly.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Related Stockholder Agreements, page&nbsp;259</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><B>41.</B></TD><TD STYLE="text-align: justify"><B>Please file the LanzaTech Investor
                                            Rights Agreement, Amended and Restated Right of First Refusal and Co-Sale Agreement, and
                                            Amended and Restated Voting Agreement as exhibits to the registration statement. Alternatively,
                                            provide an analysis supporting your belief that such filing is not required. See Item 601
                                            of Regulation S-K.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Response</U></FONT>:
The Company respectfully acknowledges the Staff&rsquo;s comment and advises the Staff that it considered the provisions of Regulation S-K Item
601 in evaluating whether the filing of the abovementioned agreements would be appropriate. The Company believes that each
of the agreements are not material to investors, as these agreements will terminate upon the closing of the Business Combination and
include no material post-closing obligations. As such, the filing of these agreements would not
provide prospective investors with meaningful additional insight into LanzaTech&rsquo;s business, risks or prospects. In light of the
foregoing, the Company respectfully submits that these agreements are not required to be filed as exhibits to the Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Exhibits and Financial Statement Schedules.,
page&nbsp;II-2</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><B>42.</B></TD><TD STYLE="text-align: justify"><B>You state in the footnotes
                                            to the Exhibit&nbsp;Index on page&nbsp;II-4 that you have omitted certain exhibits and schedules
                                            in accordance with Item 601(a)(5)&nbsp;of Regulation SK. However, it appears that you have
                                            instead redacted information from certain of these exhibits in accordance with Regulation
                                            S-K Items 601(b)(2)(ii)&nbsp;and/or 601(b)(10)(iv). Please revise to accurately denote which
                                            exhibits include redacted information and include a prominent statement on the first page&nbsp;of
                                            each redacted exhibit that certain identified information has been excluded from the exhibit
                                            because it is both not material and is the type that the registrant treats as private or
                                            confidential.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Response</U></FONT>:
In response to the Staff&rsquo;s comment, the Company has revised the description on pages&nbsp;II-2 - II-5 of Amendment No.&nbsp;1
and noted on the first page&nbsp;of each redacted exhibit that certain identified information has been excluded from the exhibit
because it is both not material and is the type that the registrant treats as private or confidential.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%">United States Securities and Exchange Commission</TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; width: 50%"><IMG SRC="tm225496d7_corresp1img001.jpg" ALT="" STYLE="height: 15px; width: 200px"></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">October 11, 2022</TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>General</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><B>43.</B></TD><TD STYLE="text-align: justify"><B>Please tell us whether Goldman
                                            Sachs was involved in the preparation of any disclosure that is included in the registration
                                            statement, including any analysis underlying the disclosure in the registration statement,
                                            or material underlying disclosure in the registration statement, including but not limited
                                            to the disclosure beginning on page&nbsp;103 regarding the financial analyses prepared by
                                            AMCI management and/or the LanzaTech Projected Financial Information beginning on page&nbsp;105.
                                            If so, clarify Goldman Sachs&rsquo; involvement, whether it has retracted any work product associated
                                            with the transaction, and also include a risk factor describing its role in connection with
                                            the preparation of the registration statement and the valuation of LanzaTech and that it
                                            disclaims any liability in connection with such disclosure included in the registration statement.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Response</U></FONT>:
The Company respectfully informs the Staff that none of Goldman Sachs, Barclays or Evercore prepared or provided any of the
disclosure in the proxy statement/prospectus or any other materials or work product. Prior to their respective resignations,
Barclays assisted LanzaTech's management and board of directors by providing general financial and capital market advisory services,
including assisting in comparable and market analysis and providing commentary thereon, and each of Goldman Sachs, Barclays and
Evercore assisted AMCI management in selecting companies to include in the Selected Public Company Analysis discussed on page 133
of the Amendment No. 1, identified potential PIPE Investors, and assisted AMCI in preparing the PIPE presentation provided to such
potential PIPE Investors. Evercore also assisted AMCI management with organizing and providing industry and market data and other
market information, as well as a financial and benchmarking analysis. None of Goldman Sachs, Barclays or Evercore were responsible
for the preparation of any materials reviewed by AMCI's board of directors or management. Further, none of Goldman Sachs, Barclays
or Evercore has retracted any work product associated with the transaction, or informed AMCI or LanzaTech or, to the knowledge of
AMCI or LanzaTech, the PIPE Investors, that any of them is in disagreement with the information previously provided to AMCI or
LanzaTech. The Company has revised the disclosure on pages&nbsp;81-86, 122, 124-129 and 135-136 of Amendment No.&nbsp;1 in response
to the Staff&rsquo;s comment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><B>44.</B></TD><TD STYLE="text-align: justify"><B>If Goldman Sachs advised AMCI
                                            on the business combination and related transactions, please add a risk factor that the board
                                            of directors of AMCI engaged with an advisor who assisted in their consideration of the transaction
                                            who has subsequently withdrawn, and explain whether the board has undertaken any additional
                                            procedures in reviewing the recommendation in light of the withdrawal of its advisor on whom
                                            it relied. If not, the AMCI board should disclose that its advisor resigned and it opted
                                            not to revisit the projections and other financial information on which it advised.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Response</U></FONT>:
The Company respectfully advises the Staff that none of Goldman Sachs, Barclays or Evercore advised AMCI on the Business Combination
or related transactions. Neither Goldman Sachs nor Barclays prepared a valuation analysis of LanzaTech in connection with the
Business Combination, nor were either of them responsible for the LanzaTech projected financial information included in the
Registration Statement. As indicated in the Company's response to Comment No. 43, in its role as financial advisor to AMCI, Evercore
assisted AMCI management with organizing and providing industry and market data and other relevant third-party market information as
well as a financial and valuation benchmarking analysis, which included a sensitivity analysis based on key drivers to LanzaTech's
business and a sum-of-the-parts analysis regarding LanzaTech's equity investment in LanzaJet. However, as indicated in the Company's
response to Comment No. 43, none of Goldman Sachs, Barclays or Evercore were responsible for the preparation of any materials
reviewed by AMCI's board of directors or management as part of their consideration of the transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%">United States Securities and Exchange Commission</TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; width: 50%"><IMG SRC="tm225496d7_corresp1img001.jpg" ALT="" STYLE="height: 15px; width: 200px"></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">October 11, 2022</TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><B>45.</B></TD><TD STYLE="text-align: justify"><B>Please disclose whether Goldman
                                            Sachs assisted in the preparation or review of any materials reviewed by the LanzaTech board
                                            of directors or management as part of its services to AMCI and whether Goldman Sachs has
                                            withdrawn its association with those materials and notified LanzaTech of such disassociation.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Response</U></FONT>:
The Company respectfully informs the Staff that Goldman Sachs, Barclays and Evercore did assist in the preparation of the PIPE
presentation that was provided to PIPE Investors as part of their services to AMCI. The PIPE presentation was reviewed by the
LanzaTech board of directors and management prior to its use. Goldman Sachs, Barclays and Evercore have not withdrawn their association with those
materials specifically and have not notified LanzaTech of such disassociation. Furthermore, as the Company has
revised disclosure on pages 127-129 of Amendment No. 1, the Company has ongoing obligations pursuant to the engagement letter that
will survive termination of engagement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><B>46.</B></TD><TD STYLE="text-align: justify"><B>Please disclose any fees paid
                                            or due to Goldman Sachs in connection with its roles as a placement agent and/or a capital
                                            markets advisor to AMCI.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Response</U></FONT>:
In response to the Staff&rsquo;s comment, the Company has revised the disclosure on pages&nbsp;99 and 124-129 of Amendment No.&nbsp;1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><B>47.</B></TD><TD STYLE="text-align: justify"><B>We note your disclosure on
                                            page&nbsp;112 that Goldman Sachs will not be receiving any compensation for serving as a
                                            placement agent in the Private Placement and as a capital markets advisor to AMCI. Please
                                            add a risk factor that discloses that such services have already been rendered, yet Goldman
                                            Sachs is waiving such fees and disclaiming responsibility for the Form&nbsp;S-4 registration
                                            statement. Clarify the unusual nature of any such fee waiver and the impact of it on the
                                            evaluation of the business combination.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Response</U></FONT>:
The Company respectfully informs the Staff that Goldman Sachs, Barclays and Evercore had not substantially rendered the services for
which they were engaged by AMCI at the time of their resignation. Instead, had Goldman Sachs, Barclays and Evercore not resigned from their roles as a capital
markets advisors to AMCI and  placement agents in the Private Placement, Goldman Sachs,  Evercore and Barclays, who
have also resigned from their roles as co-placement agents, would have remained responsible for continued outreach to various
potential PIPE Investors to help secure the Proposed Additional Financing and, unless waived, reach the Minimum Closing Cash
Condition that is required to consummate the Business Combination. In response to the Staff&rsquo;s comment, the Company has revised
the disclosure on pages&nbsp;85 and 99 of Amendment No.&nbsp;1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><B>48.</B></TD><TD STYLE="text-align: justify"><B>Disclose whether Goldman Sachs
                                            provided you with any reasons for the fee waiver. If there was no dialogue and you did not
                                            seek out the reasons why Goldman Sachs was waiving deferred fees, despite already completing
                                            their services, please indicate so in your registration statement. Further, revise the risk
                                            factor disclosure to explicitly clarify that Goldman Sachs has performed all of its obligations
                                            to obtain this fee and therefore is gratuitously waiving the right to be compensated.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Response</U></FONT>:
The Company respectfully advises the Staff that Goldman Sachs, Barclays and Evercore did not provide any reasons for the fee waiver. As indicated in the
Company&rsquo;s response to Comment No.&nbsp;47, the Company respectfully informs the Staff that Goldman Sachs, Barclays and Evercore had not completed their
services when they advised the Company of their resignation. In response to the Staff&rsquo;s comment, the Company has revised the
disclosure on pages&nbsp;85-86, 122, 124 and 126 of Amendment No.&nbsp;1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%">United States Securities and Exchange Commission</TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; width: 50%"><IMG SRC="tm225496d7_corresp1img001.jpg" ALT="" STYLE="height: 15px; width: 200px"></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">October 11, 2022</TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><B>49.</B></TD><TD STYLE="text-align: justify"><B>Please add a risk factor disclosing
                                            the following:</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><B>&bull; When a financial institution
is named in a proxy statement/prospectus such as this, it typically presumes a level of due diligence and independent analysis on the
part of such financial institution, and it also typically means that a financial institution has done a level of due diligence ordinarily
associated with a professional engagement.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><B>&bull; By
withdrawing, Goldman Sachs is indicating that it does not want to be associated with the disclosure or the underlying business
analysis related to the transaction. Accordingly, your disclosure should caution investors that they should not place any reliance
on the fact that Goldman Sachs has been previously involved with this transaction.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Response</U></FONT>:
In response to the Staff&rsquo;s comment, the Company has revised the disclosure on pages&nbsp;81-86 and 99 of Amendment No.&nbsp;1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><B>50.</B></TD><TD STYLE="text-align: justify"><B>Please provide us with a letter
                                            from Goldman Sachs stating whether it agrees with the statements made in your prospectus
                                            related to their resignation and, if not, stating the respects in which it does not agree.
                                            Please revise your disclosure accordingly to reflect that you have discussed the disclosure
                                            with Goldman Sachs and it either agrees or does not agree with the conclusions and the risks
                                            associated with such outcome. If Goldman Sachs does not respond, please revise your disclosure
                                            to indicate you have asked and not received a response and disclose the risks to investors.
                                            Additionally, please indicate that you will not speculate about the reasons that Goldman
                                            Sachs withdrew from its role as placement agent and capital markets advisor and forfeited
                                            its fees, if applicable. The disclosure should clarify whether Goldman Sachs performed substantially
                                            all the work to earn these fees.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Response</U></FONT>:
The Company respectfully informs the Staff that AMCI requested a letter from each of Goldman Sachs, Barclays and Evercore stating
whether it agrees with the statements made in the proxy statement/prospectus related to its respective resignation and, if not,
stating the respects in which it does not agree. Following delivery of the proxy statement/prospectus to each of Goldman Sachs,
Barclays and Evercore, they have either not responded or have responded that they do not intend to review the disclosure. As
requested by the Staff, the Company has revised the disclosure on pages&nbsp;81-86 of Amendment No.&nbsp;1 to state that Goldman
Sachs, Barclays and Evercore either did not respond or declined to review the proxy statement/prospectus, that none of Goldman
Sachs, Barclays or Evercore provided a letter to AMCI regarding whether it agreed or did not agree with the statements included in
the proxy statement/prospectus and that, accordingly, no inference should be drawn that any of Goldman Sachs, Barclays or Evercore
agrees with the disclosure regarding its respective resignation. Further, in response to the Staff&rsquo;s comment, the Company
undertakes that it will not speculate in the Registration Statement (or any amendments thereto) or make any public statements about
the reasons why any of Goldman Sachs, Barclays or Evercore withdrew from its respective advisory role. As indicated in the
Company&rsquo;s response to Comment No.&nbsp;47, the Company respectfully informs the Staff that none of Goldman Sachs, Barclays or
Evercore had completed its respective services when it advised the Company of its resignation. Furthermore, in response to the
Staff&rsquo;s comment, the Company has revised the disclosure on pages&nbsp;81-86 and 99 of Amendment No.&nbsp;1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><B>51.</B></TD><TD STYLE="text-align: justify"><B>Please tell us whether you
                                            are aware of any disagreements with Goldman Sachs regarding disclosure in the financial statements
                                            in the Form&nbsp;S-4 registration statement.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Response</U></FONT>:
The Company respectfully advises the Staff that it is not aware of any disagreements with Goldman Sachs, Barclays and Evercore regarding the disclosure in the
financial statements included in the Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%">United States Securities and Exchange Commission</TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; width: 50%"><IMG SRC="tm225496d7_corresp1img001.jpg" ALT="" STYLE="height: 15px; width: 200px"></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">October 11, 2022</TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><B>52.</B></TD><TD STYLE="text-align: justify"><B>In light of the resignation
                                            of Goldman Sachs, please describe the extent to which the availability of financing that
                                            is currently contemplated could be curtailed and how you would expect to manage such a change.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Response</U></FONT>:
The Company respectfully advises the Staff that it does not believe that the resignation of Goldman Sachs, Barclays and Evercore will impact the availability
of financing. The Company does not expect to
hire another placement agent in connection with the Business Combination. The Company has revised the disclosure on pages&nbsp;126-129 of Amendment No.&nbsp;1 accordingly.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><B>53.</B></TD><TD STYLE="text-align: justify"><B>Please provide us with the
                                            engagement letter between Goldman Sachs and AMCI. Please disclose any ongoing obligations
                                            of AMCI pursuant to the engagement letter that will survive the termination of the engagement,
                                            such as indemnification provisions, and discuss the impact of those obligations on AMCI in
                                            the registration statement.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Response</U></FONT>:
In response to the Staff&rsquo;s comment, the Company has submitted the engagement letter between AMCI and each of Goldman Sachs,
Barclays and Evercore along with their amendments, to the Staff via Kiteworks secure file transfer system. Furthermore, in response
to the Staff&rsquo;s comment, the Company has revised the disclosure on&nbsp;pages 127-129 of Amendment No.&nbsp;1 to disclose the
ongoing obligations of the Company pursuant to the engagement letter that will survive termination of the engagement and to discuss
the impact of those obligations on the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><B>54.</B></TD><TD STYLE="text-align: justify"><B>Please provide us with any
                                            correspondence between Goldman Sachs and AMCI relating to Goldman Sachs&rsquo; resignation.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Response</U></FONT>:
The Company respectfully informs the Staff that there was no correspondence between any of Goldman Sachs, Barclays or Evercore and
the Company relating to any of their resignations other than their respective notices and formal letters.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><B>55.</B></TD><TD STYLE="text-align: justify"><B>We note that LanzaTech&rsquo;s website
                                            continues to list Goldman Sachs as an advisor on the transaction under the Investor Relations
                                            tab. Please explain.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Response</U></FONT>:
The Company respectfully acknowledges the Staff&rsquo;s comment and advises the Staff that LanzaTech&rsquo;s website has been updated
such that the Investor Relations tab does not immediately direct visitors to the press release announcing the signing of the transaction,
which listed Goldman Sachs, Barclays and Evercore as advisors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">* * *</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%">United States Securities and Exchange Commission</TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; width: 50%"><IMG SRC="tm225496d7_corresp1img001.jpg" ALT="" STYLE="height: 15px; width: 200px"></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">October 11, 2022</TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Please do not hesitate
to contact Elliott Smith  of White&nbsp;&amp; Case LLP at (212) 819-7644 with any questions or comments regarding
this letter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Sincerely,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">/s/ White&nbsp;&amp; Case LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">White&nbsp;&amp; Case LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left">cc:</TD><TD STYLE="text-align: justify">Nimesh Patel, AMCI Acquisition Corp. II</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 18; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>tm225496d7_corresp1img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm225496d7_corresp1img001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  ; 6,# 2(  A$! Q$!_\0
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2_P 511?!=I?@'+FG\T/N9__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>tm225496d7_corresp1img002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm225496d7_corresp1img002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !J ,(# 2(  A$! Q$!_\0
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M:1HRNB-I]@&?.U3"F6^G'-'N>?X!>IV7WO\ R-&BJ/\ 8FD_] RR_P# =/\
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MWLF"DXMY+H1\@1&1#,#UX";P?8&DN[[1[&UNIM'DMX[@B"-Y+0)M 9\+DGY
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MKF/)&TNV.>W0#@$G=F\0Z7!''*]UNB>$7 DCC9T6(]'9E!"J?4X& 3T!QIT
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AV"BBBLCH"BBB@ HHHH **** "BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
